The One Big Beautiful Bill Act may offer some positives for health care in general and rheumatology specifically, according to Christina Downey, MD, chair of the American College of Rheumatology ...

The Food and Drug Administration will miss a deadline this week deciding whether to approve a drug for a potentially ...